Keratinocyte growth factor ameliorates mycophenolate mofetil-induced intestinal barrier disruption in mice

• Published in: Molecular immunology 2020-08, Vol.124, p.61-69
• Main Authors: Song, Yajun, Hu, Wengang, Xiao, Ya, Li, Yang, Wang, Xu, He, Weifeng, Hou, Jingming, Liu, Yun, Liang, Guangping, Huang, Chibing
• Format: Article
• Language: English
• Subjects: adults; apoptosis; Gastrointestinal side effect; histopathology; immunology; intraperitoneal injection; Keratinocyte growth factor; keratinocytes; males; Mycophenolate mofetil; permeability; protective effect; protein synthesis; therapeutics; tight junctions; γδ+intraepithelial lymphocyte
• ISSN: 0161-5890; 1872-9142
• DOI: 10.1016/j.molimm.2020.04.012

•Mycophenolate mofetil (MMF) induced gastrointestinal disruption and increased intestinal mucosal permeability in a mouse model.•KGF maintained tight junction protein, reversed proliferative inhibition and suppressed the apoptosis of intestinal epithelial cells.•KGF significantly enhanced the proportion of γδ+T intraepithelial lymphocytes. Although mycophenolate mofetil-induced (MMF) effectively improves long-term graft survival, the gastrointestinal (GI) side effects due to MMF-induced GI barrier damage limit its use in clinic. Keratinocyte growth factor (KGF) plays a crucial role in the intestinal protection and repair process. This study is designed to investigate the protective effect of KGF on MMF-induced intestinal mucosal barrier disruption and the potential mechanism. Thirty adult male C57BL/6 mice were assigned to one of the following groups: the MMF group, the MMF + KGF group, and the control group (n = 10 in each group). Animals in the MMF group received MMF (500 mg/kg) by gavage once daily for 15 consecutive days; animals in the MMF + KGF group received MMF (500 mg/kg) by gavage and KGF (5 mg/kg) by intraperitoneal injection once daily for 15 consecutive days; and control mice were given an equal volume of vehicle during the 15-day experimental period. In each group, intestinal paracellular permeability, histopathological changes and shifts in tight junction (TJ) protein were evaluated; further, proliferation and apoptosis of intestinal epithelial cells (IECs) were assessed, and intraepithelial lymphocytes (IELs) were isolated and analyzed by flow cytometry. MMF caused intestinal mucosal injury, increased intestinal mucosal permeability, and altered expression of TJ protein. Moreover, MMF treatment inhibited IEC proliferation and increased apoptosis. MMF treatment resulted in a lower proportion of γδ+ T cells in IELs (γδ+ IELs). Conversely, concurrent administration of KGF with MMF effectively alleviated MMF-induced intestinal mucosal disruption, inhibited the increase in intestinal permeability, and maintained TJ protein expression. KGF also reversed the MMF-mediated inhibition of proliferation and promotion of apoptosis in IECs. In addition, KGF significantly enhanced the proportion of γδ+ IELs. Our findings suggest that MMF induces intestinal epithelial barrier disruption in mice. KGF may play a protective role to ameliorate the disruption and provide a therapeutic intervention for gastrointestinal disorders induced by MMF.